Search This Blog

Monday, December 31, 2018

Cipla recalls HIV med from US


The US Food and Drug Administration (USFDA) has said that Pharmaceutical major Cipla Limited has recalled 4,800 bottles of Nevirapine extended release tablets (400 mg) indicated for the treatment of human immunodeficiency virus (HIV) from the US market. The drug manufactured at the Goa facility is being recalled due to ‘failed dissolution specifications’.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.